Home › Markets › Health Care › IART

Integra LifeSciences Holdings Corporation (IART)

IART trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$13.85
-0.93% on the day
Market cap
$1.1B
Small cap
Revenue · 2025
$1.6B
+1.5% on 2024
Net income · 2025
-$516.8M
-31.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerIART on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000917520
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.6B
Net income-$516.8M
Operating income-$493.4M
Net margin-31.6%
Operating margin-30.2%
Revenue growth+1.5%
Cash$235.0M
Total assets$3.6B
P/E (computed)Net income was not positive
P/S (computed)0.7×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-02-26
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-07-29
Latest current report8-K2026-10-09
Latest proxyDEFA14A2026-05-05

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.5%
1 month-15.9%
3 months-33.5%
Year to date+6.3%
1 year-3.1%
From 52-week high-33.5%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
PRCTPROCEPT BioRobotics Corporation$19.10-2.40%$1.1B
AORTArtivion Inc.$21.36-1.97%$1.0B
BVSBioventus Inc.$13.56+0.22%$1.1B
IRMDiRadimed Corporation$89.65+0.20%$1.1B
TNDMTandem Diabetes Care Inc.$16.65+1.22%$1.2B
BBNXBeta Bionics Inc.$17.69-0.95%$931.2M
DRTSAlpha Tau Medical Ltd.$13.74-3.65%$1.3B
SIBNSI-BONE Inc.$19.68-2.09%$882.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier